TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in School Belonging Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Adrenal insufficiency symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-surgical pain perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients losing fewer than 15 letters on EDTRS chart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health related quality of life assessed by SF-36 sub scale bodily pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Abrasion Assessment (Number)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Abrasion Assessment (Size)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mucosal Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurological outcome at D90 assessed by modified Rankin scale (mRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adult intelligence quotient (IQ) score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time in Range (TIR) for blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in hemoglobin concentration ≥ 20 g/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: SF36 Physical Function Subscale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Senior Fitness Test Battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of peripheral blood characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of gut microbiome components
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of Gold standard #1 diagnosis in trainee list
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor shrinkage (response rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Efficacy of ssCART-19 cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AUC0-24 of lumefantrine in maternal plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-24 of lumefantrine in breastmilk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Milk to plasma ratio of lumefantrine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak plasma concentration (Cmax) of Rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC) of Rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC) of Digoxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak plasma concentration (Cmax) of GP681
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine specific antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse event rate through end of treatment period
Endpoint domain: Adverse events/effects
Primary endpoint: Serious adverse event rate through end of treatment period
Endpoint domain: Adverse events/effects
Primary endpoint: Death all cause
Endpoint domain: Mortality/survival
Primary endpoint: Risk factors for intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Risk factors for death
Endpoint domain: Mortality/survival
Primary endpoint: Satisfaction with tracking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent sensor glucose time-in-range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in lean soft tissue mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 3-year radiographic progression free survival (rPFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: epitope numbers of acid-alpha-glucosidase antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: epitope locations of acid-alpha-glucosidase antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: epitope-specific affinities of acid-alpha-glucosidase antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of septic biomarker levels IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse event (AE) reporting
Endpoint domain: Adverse events/effects
Primary endpoint: WOMAC SCALE
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Prevention of clinical worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of lung function worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of time spent in a joint attention situation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Prevalence of organizing pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sacroiliac Joint Dysfunction Tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 7-day bowel diary
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in arthralgia scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Adherence to DistaSense
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient acceptance of DistaSense
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection of COPD exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: serial changes of survival
Endpoint domain: Mortality/survival
Primary endpoint: serial changes of plasma vh-DNA copies associated with overall survival
Endpoint domain: Mortality/survival
Primary endpoint: Change in co-PA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in intensity of PA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of transitional regulatory B cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Recommended phase 2 dose (RP2D) of apatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number and severity of Allocetra-OTS related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number and severity of serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Pain Interference with Work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Pain Interference with Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: variation of side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients remaining in clinical research until completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: time-to-discharge readiness
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total analgesic requirements of morphine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The occurrence rate of all adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Granuloma formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Bisphenol-A amount in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of cochlear microphonics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary protein-to-creatinine ratio (UPCR) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of completed guideline-recommended quality checklist items
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Development of progressive pulmonary fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of HyFoSy in assessing tubal patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Frequency of IV dislodgements
Endpoint domain: Adverse events/effects
Primary endpoint: Mean amount of time spent in AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: System Usability Scale (ISUS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Program Completion Statistics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Attention/ concentration score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Working memory score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Executive function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patient's obesity relevant knowledge pre- and post-education intervention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of patients who chose to take part in bariatric surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Connection with nature
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fugl Meyer for Upper Limb (FM) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of accidental gas leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adherence to scheduled doses
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Dose of nitroglycerine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Whole-mouth Mean Turesky Plaque Index (TPI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long covid related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Pittsburgh sleep quality index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Cognitive function-Digit symbol substitution test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive function-The Montreal Cognitive Assessment(MoCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perception of joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Joint status with Hemophilia Joint Health Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pain rating during the tampon test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure pain threshold (PPT) at the posterior vaginal fourchette
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength of cortical and trabecular bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Disability of lower back
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functional Responder Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in capability
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Time until decrease in quality of life by 5-points
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Identification of antibiotic susceptibility pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Detection of virulence and antibiotic resistance genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of patients with favourable study outcome
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: AUROC for Classification of Necessity for Massive Transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consumer awareness regarding wholegrains
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Wholegrain consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall hangover severity rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Successful performing of retinal oximetry images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful analysis of retinal oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of chemotherapy-induced febrile neutropenia-related hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of chemotherapy-induced febrile neutropenia-related hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Time to cancer progression
Endpoint domain: Mortality/survival
Primary endpoint: number of hypotensive episodes per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of severe hypotensive episodes per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Health-related quality-of-life (HrQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: incidence of central obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of triglyceridemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of dyslipidemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of systemic hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of glucose intolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants Who Had Progression of COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Change in colony forming units
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Patients' Evaluation of Quality of Diabetes Care (PEQD)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived Quality of Medical Care (PQMC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reliability of respiratory acoustics at detecting airflow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Central visual field deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Waist and hips circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daytime Percent Time-in-range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended Dose Escalation (RDE)
Endpoint domain: Physiological/clinical
Primary endpoint: Enteral tube position accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of specific strains of Pneumocystis jirovecii
Endpoint domain: Adverse events/effects
Primary endpoint: Macrovascular endothelial function at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Microvascular endothelial function at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Brachial artery blood flow at rest and during rhythmic handgrip exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Forearm muscle oxygenation at rest and during rhythmic handgrip exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in barriers to return to work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Histopathological tumor response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants in Disease Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Number of Unplanned Acute Care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants with blunted dipping of blood pressure via the sleep based method
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with blunted dipping of blood pressure via the wide fixed time method
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with unhealthy Heart Rate Variability (HRV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bone mineral density score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accrual rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Retention rate / acceptability
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: microparticle concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: phenotyping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lipid composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Risk of eating disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Maximal strength horizontal pull based on the execution velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Maximal strength bench press based on the execution velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Maximal strength squat based on the execution velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lab measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PROs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diabetes self-care behaviors scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection of beta hCG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Functional Assessment of Cancer Therapy (FACT) -Taxane
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Healing performance of the VistaCare® device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Wound healing outcomes
Primary endpoint: Patient unmet needs
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Maximal inspiratory pressure (MIP) measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Modified Medical Research Council (mMRC) Dyspnea Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Level of CRP in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Effectiveness of the intervention on implementing shared decision making
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Degree of involvement of patients by the clinician in the shared decision making
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Provider satisfaction with NSCLC choice conversation aid
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in leukocyte subpopulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Recommended phase II clinical study dose (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV viral control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: intraoperative non invasive blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of macrophage-derived autophagosomes in alveolar lavage fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of ARDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of bleeding/ suppuration on probing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in probing depth ≤ 1mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of additional bone loss after therapy of more than 5mm from radiographic baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with presence of antibodies titres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Comparison of safety profile of AZD1222 (Covishield)
Endpoint domain: Adverse events/effects
Primary endpoint: basal insulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fall rate due to sit to stand transition detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes